BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessCURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of DirectorsBy Nasdaq OMXMay 3, 2017, 1:01 PM UTC
BusinessAXIM Biotech Receives Schedule 1 Permit to Move Forward With Development of MedChew Rx Pharmaceutical Chewing GumBy Nasdaq OMXMay 2, 2017, 1:00 PM UTC
BusinessEarth Science Tech, Inc. Targets Breast Cancer and Other Women's Health Issues in New Cannabis CBD-Based Pharmaceutical Drug Development InitiativesBy Nasdaq OMXApr 11, 2017, 11:45 AM UTC
BusinessAXIM Biotech to Attend Biocentury’s 24th Annual Future Leaders in the Biotech Industry Conference in New YorkBy Nasdaq OMXApr 5, 2017, 1:01 PM UTC
BusinessMadrigal Pharmaceuticals Reports 2016 Fourth Quarter and Year-End Financial Results, Reviews Key Corporate Achievements and Provides Update on Lead Clinical-stage Compound, MGL-3196By Nasdaq OMXApr 3, 2017, 11:30 AM UTC
BusinessAXIM Biotech Enters Term Sheet Agreement With US API Company to Develop Bioequivalent Product to MarinolBy Nasdaq OMXMar 28, 2017, 1:01 PM UTC
BusinessEarth Science Tech, Inc. Announces Timeline Projection for its MSN-2 Medical Device, and Partnership Negotiations for its Cannabis CBD-Based Generic Drugs & Medical Device DistributionBy Nasdaq OMXMar 27, 2017, 4:12 PM UTC
